Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

925
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
925
Cancer Vaccines01:30

Cancer Vaccines

945
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
945

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical Routes to Primitive Membranes: Prebiotic Lipid Formation at the Origin of Life.

Life (Basel, Switzerland)·2026
Same author

Author Correction: A scope of prebiotic neat reaction conditions and the mechanism of urea-assisted phosphorylations of alcohols.

Nature communications·2026
Same author

A scope of prebiotic neat reaction conditions and the mechanism of urea-assisted phosphorylations of alcohols.

Nature communications·2025
Same author

Cathepsin K Inhibitors as Potential Drugs for the Treatment of Osteoarthritis.

International journal of molecular sciences·2025
Same author

A protein corona modulates the function of mineralization-competent matrix vesicles.

JBMR plus·2025
Same author

From the RNA-Peptide World: Prebiotic Reaction Conditions Compatible with Lipid Membranes for the Formation of Lipophilic Random Peptides in the Presence of Short Oligonucleotides, and More.

Life (Basel, Switzerland)·2024

Related Experiment Video

Updated: Jan 13, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.0K

Liposome-Based Potential Vaccines Platforms that Are Noncytotoxic.

Saida Mebarek1, Killian Jacob1, Carmela Ilaria Pierro1,2

  • 1Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, ICBMS, UMR 5246, CNRS, Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France.

Chemistryopen
|January 11, 2026
PubMed
Summary

Researchers developed a novel liposomal synthetic vaccine platform using neoglycolipids. This cancer immunotherapy approach shows promise with no detectable cytotoxicity and stable formulation, offering a tunable delivery system.

Keywords:
glycolipidsliposomesnanomedicinetn antigenvaccine platform

More Related Videos

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.1K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.7K

Related Experiment Videos

Last Updated: Jan 13, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.0K
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.1K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.7K

Area of Science:

  • Biotechnology
  • Immunology
  • Materials Science

Background:

  • Synthetic vaccines are key in cancer immunotherapy.
  • Liposomal delivery enhances synthetic vaccines for tumor antigens.
  • Toxicity and reproducibility of current platforms require further investigation.

Purpose of the Study:

  • To synthesize neoglycolipids with the Thomsen-Nouveau (Tn) antigen.
  • To evaluate their self-assembly into liposomal vesicles.
  • To assess in vitro cytotoxicity for a novel vaccine platform.

Main Methods:

  • Bio-orthogonal thiol-ene click chemistry for neoglycolipid synthesis.
  • Formulation with palmitic acid and specific phospholipids.
  • Freeze-thaw/extrusion process for liposome formation.
  • In vitro cytotoxicity assays.

Main Results:

  • Synthesized neoglycolipids successfully self-assembled into stable liposomal structures.
  • The resulting liposomes showed no detectable cytotoxicity.
  • The platform demonstrated proof of concept for tunable liposomal vaccine delivery.

Conclusions:

  • Neoglycolipids can form stable, non-toxic liposomal structures.
  • This represents a tunable, liposomal-based synthetic vaccine platform.
  • Further development is warranted for cancer immunotherapy applications.